Plain-English translation of NCT07375069 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →CardioMET is a large information-gathering study that follows people with type 2 diabetes across Italy. Researchers are collecting details about patients' heart health risks and the medications they're taking to manage their diabetes. The goal is to understand how well current treatment guidelines are working in real-world doctor's offices and hospitals.
Many people with type 2 diabetes are at higher risk for heart disease, but doctors aren't always sure they're following the best treatment guidelines. This study will show how Italian doctors are currently managing these patients and whether there are ways to better protect their hearts.
You likely qualify if…
You likely don't qualify if…
You would visit your regular doctor's clinic as you normally would. Researchers would review your medical records, including information about your diabetes diagnosis, heart health, and current medications. There are no special tests or procedures required — this is simply a way of collecting and studying information from people like you who are already receiving diabetes care.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
Italy
Federico II University
Enrollment target
~3,000 participants
Started
October 2022
Primary completion
October 2023
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Pasquale Perrone Filardi
Federico II University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.